Search results
Alicia Okines
Research Area(s) / Expertise:
Job title: Consultant Medical Oncologist, Royal Marsden Hospital, London, UK
Author
Author(s):
Dhanunjaya Lakkireddy
Added:
2 years ago
Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Overland Park, KS, US) sits down to discuss the findings of the STROKE-VT Trial, which investigated the use of aipaxaban in reducing blood clots and stroke risk after an ablation procedure.
Questions:
1. Please summarise the aim, study design and endpoints?
2. What were your major findings?
3. What further research is required?
4…
View more
Author(s):
Prof José C Nicolau
,
Christopher B Granger
Added:
6 years ago
Explore the safety and efficacy of ticagrelor compared with clopidogrel in patients with acute coronary syndrome with ST elevation treated with thrombolysis - ACC 2018
An expert peer-to-peer discussion on the latest data to come out of the TREAT trial and its implications for clinical practice.
Sunday 11th March 2018 @ 15:00 EST
ACC.18 Congress, Orlando, FL
Discussants: Dr Christopher Granger …
View more
Author(s):
Steven R Sigman
Added:
3 years ago
Although less common than other forms of cardiomyopathy, cardiac sarcoidosis (CS), both as part of a systemic process and in its isolated form, is an important, and increasingly recognized disorder. This is felt to be due, in part, to advances in cardiac imaging and heightened awareness of the disorder.1,2 CS is associated with high rates of morbidity and mortality, including sudden cardiac death…
View more
Author(s):
Debra Green
,
Jack E Ansell
,
Stephan Moll
Added:
3 years ago
Oral anticoagulants are one of the most common causes of drug-induced adverse events.1 Expert dose management, which keeps the patient within a narrow therapeutic international normalized range (INR), is required to avoid adverse events and optimize therapy. Anticoagulation clinic (ACC) management has been shown to improve outcomes compared with the routine management provided by physicians,2 but…
View more
Author(s):
Paulus Kirchhof
Added:
7 months ago
ESC 2023 — Prof Paulus Kirchhof (University Heart & Vascular Center Hamburg, DE) discusses the findings of the NOAH-AFNET 6 trial (NCT02618577).
NOAH-AFNET 6 (Atrial Fibrillation Network, Daiichi Sankyo Europe) was an investigator-initiated, prospective, randomised trial aiming to demonstrate that oral anticoagulation using the NOAC edoxaban is superior to current therapy in stroke prevention,…
View more
Amyloid Heart Disease
Author(s):
Yaser Nemshah
,
Alex Clavijo
,
Gyanendra Sharma
Added:
3 years ago
Article
Author(s):
Catherine R Weinberg
,
Amier Ahmad
,
Boyangzi Li
,
et al
Added:
3 years ago
Dyspnea, palpitations, edema, and fatigue are common symptoms during pregnancy. For women with congenital heart disease (CHD), it may be difficult to discern whether symptoms are due to normal pregnancy or underlying cardiac disease. Although most women with CHD tend to experience successful pregnancies, morbidity and mortality are significantly increased with more complex CHD lesions.1–6 Women…
View more
Author(s):
Alexander Fanaroff
Added:
5 months ago
Stay up-to-date with the latest data in cardiovascular science with the help of renowned experts and emerging voices who offer concise summaries, in-depth discussions, and critical reviews to keep you informed.In their regular View from the Thoraxcenter series, Prof Van Mieghem and Dr Daemen provide valuable insights into the most anticipated trials of AHA 23. With their keen awareness of…
View more
Coarctation: A Review
Author(s):
Marc G Cribbs
Added:
3 years ago
Article